Tricyclic Triazoles as σ1 Receptor Antagonists for Treating Pain
- 7 April 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (8) , 5157-5170
Abstract
The synthesis and pharmacological activity of a new series of 5a,7,8,8a-tetrahydro-4H,6H-pyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine derivatives as potent sigma-1 receptor (σ1R) ligands are reported. A lead optimization program aimed at improving the aqueous solubility of parent racemic nonpolar derivatives led to the identification of several σ1R antagonists with a good absorption, distribution, metabolism, and excretion in vitro profile, no off-target affinities, and characterized by a low basic pKa (around 5) that correlates with high exposure levels in rodents. Two compounds displaying a differential brain-to-plasma ratio distribution profile, 12lR and 12qS, exhibited a good analgesic profile and were selected as preclinical candidates for the treatment of pain.Keywords
Funding Information
- European Regional Development Fund
- Ministerio de Economía y Competitividad (IDI-20110577, IDI-20130942, IDI-20150914)
This publication has 50 references indexed in Scilit:
- Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat PainPharmacological Reviews, 2012
- Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)Journal of Medicinal Chemistry, 2012
- ShelXle: a Qt graphical user interface forSHELXLJournal of Applied Crystallography, 2011
- Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding siteNature Communications, 2011
- The sigma-1 receptor chaperone as an inter-organelle signaling modulatorTrends in Pharmacological Sciences, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Intramolecular Azide−Alkyne Cycloaddition for the Fast Assembly of Structurally Diverse, Tricyclic 1,2,3-TriazolesOrganic Letters, 2008
- Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)Biochemical and Biophysical Research Communications, 1996
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983